Which has better valuation & earnings, GMVDF or TTOO?

G Medical Innovations has higher earnings, but lower revenue than T2 Biosystems. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio G Medical Innovations $4.42M 0.00 -$24.63M N/A N/A T2 Biosystems $7.68M 0.01 -$50.08M -$3.89 N/A

Is GMVDF or TTOO more profitable?

G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%. Company Net Margins Return on Equity Return on Assets G Medical Innovations N/A N/A N/A T2 Biosystems -563.16% N/A -174.06%

Which has stronger valuation & earnings, GMVDF or SDCCQ?

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio G Medical Innovations $4.42M 0.00 -$24.63M N/A N/A SmileDirectClub $470.74M 0.00 -$86.40M -$0.29 N/A

Is GMVDF or SDCCQ more profitable?

Company Net Margins Return on Equity Return on Assets G Medical Innovations N/A N/A N/A SmileDirectClub N/A N/A N/A

Which has stronger valuation and earnings, GMVDF or VRAYQ?

G Medical Innovations has higher earnings, but lower revenue than ViewRay. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio G Medical Innovations $4.42M 0.00 -$24.63M N/A N/A ViewRay $102.21M 0.00 -$107.33M -$0.31 N/A

Is GMVDF or VRAYQ more profitable?

Company Net Margins Return on Equity Return on Assets G Medical Innovations N/A N/A N/A ViewRay N/A N/A N/A

Which has better earnings and valuation, AFIB or GMVDF?

G Medical Innovations has lower revenue, but higher earnings than Acutus Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Acutus Medical $7.16M 0.00 -$81.66M -$0.11 N/A G Medical Innovations $4.42M 0.00 -$24.63M N/A N/A

Which has better earnings & valuation, UTRS or GMVDF?

G Medical Innovations has lower revenue, but higher earnings than Minerva Surgical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Minerva Surgical $51.69M 0.00 -$34.11M -$4.21 N/A G Medical Innovations $4.42M 0.00 -$24.63M N/A N/A

Is UTRS or GMVDF more profitable?

Company Net Margins Return on Equity Return on Assets Minerva Surgical N/A N/A N/A G Medical Innovations N/A N/A N/A

G Medical Innovations (GMVDF) Competitors

Compare

GMVDF vs. TTOO, SDCCQ, VRAYQ, AFIB, and UTRS

Should you buy G Medical Innovations stock or one of its competitors? MarketBeat compares G Medical Innovations with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with G Medical Innovations include T2 Biosystems (TTOO), SmileDirectClub (SDCCQ), ViewRay (VRAYQ), Acutus Medical (AFIB), and Minerva Surgical (UTRS). These companies are all part of the "medical equipment" industry.

How does G Medical Innovations compare to T2 Biosystems?

G Medical Innovations (NASDAQ:GMVDF) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company	Net Margins	Return on Equity	Return on Assets
G Medical Innovations	N/A	N/A	N/A
T2 Biosystems	-563.16%	N/A	-174.06%

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

G Medical Innovations has a beta of 27.28, indicating that its share price is 2,628% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 7.71, indicating that its share price is 671% more volatile than the broader market.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company	Overall Sentiment
G Medical Innovations	Neutral
T2 Biosystems	Neutral

G Medical Innovations has higher earnings, but lower revenue than T2 Biosystems.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
G Medical Innovations	$4.42M	0.00	-$24.63M	N/A	N/A
T2 Biosystems	$7.68M	0.01	-$50.08M	-$3.89	N/A

Summary

G Medical Innovations beats T2 Biosystems on 5 of the 7 factors compared between the two stocks.

How does G Medical Innovations compare to SmileDirectClub?

G Medical Innovations (NASDAQ:GMVDF) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

G Medical Innovations has a beta of 27.28, meaning that its share price is 2,628% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company	Overall Sentiment
G Medical Innovations	Neutral
SmileDirectClub	Neutral

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
G Medical Innovations	N/A	N/A	N/A
SmileDirectClub	N/A	N/A	N/A

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
G Medical Innovations	$4.42M	0.00	-$24.63M	N/A	N/A
SmileDirectClub	$470.74M	0.00	-$86.40M	-$0.29	N/A

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to ViewRay?

G Medical Innovations (NASDAQ:GMVDF) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

G Medical Innovations has higher earnings, but lower revenue than ViewRay.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
G Medical Innovations	$4.42M	0.00	-$24.63M	N/A	N/A
ViewRay	$102.21M	0.00	-$107.33M	-$0.31	N/A

G Medical Innovations has a beta of 27.28, meaning that its share price is 2,628% more volatile than the broader market. Comparatively, ViewRay has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
G Medical Innovations	N/A	N/A	N/A
ViewRay	N/A	N/A	N/A

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 15.5% of ViewRay shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by insiders. Comparatively, 2.5% of ViewRay shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, ViewRay had 1 more articles in the media than G Medical Innovations. MarketBeat recorded 1 mentions for ViewRay and 0 mentions for G Medical Innovations. G Medical Innovations' average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company	Overall Sentiment
G Medical Innovations	Neutral
ViewRay	Neutral

Summary

G Medical Innovations and ViewRay tied by winning 3 of the 6 factors compared between the two stocks.

How does G Medical Innovations compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

G Medical Innovations has lower revenue, but higher earnings than Acutus Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acutus Medical	$7.16M	0.00	-$81.66M	-$0.11	N/A
G Medical Innovations	$4.42M	0.00	-$24.63M	N/A	N/A

Acutus Medical has a beta of 5.67, indicating that its share price is 467% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 27.28, indicating that its share price is 2,628% more volatile than the broader market.

G Medical Innovations has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. G Medical Innovations' return on equity of 0.00% beat Acutus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acutus Medical	-272.74%	-311.64%	-11.57%
G Medical Innovations	N/A	N/A	N/A

56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Comparatively, 37.1% of G Medical Innovations shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company	Overall Sentiment
Acutus Medical	Neutral
G Medical Innovations	Neutral

Summary

G Medical Innovations beats Acutus Medical on 6 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

6.0% of G Medical Innovations shares are held by institutional investors. 8.5% of Minerva Surgical shares are held by company insiders. Comparatively, 37.1% of G Medical Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company	Overall Sentiment
Minerva Surgical	Neutral
G Medical Innovations	Neutral

G Medical Innovations has lower revenue, but higher earnings than Minerva Surgical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Minerva Surgical	$51.69M	0.00	-$34.11M	-$4.21	N/A
G Medical Innovations	$4.42M	0.00	-$24.63M	N/A	N/A

Minerva Surgical has a beta of 2.92, indicating that its share price is 192% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 27.28, indicating that its share price is 2,628% more volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
Minerva Surgical	N/A	N/A	N/A
G Medical Innovations	N/A	N/A	N/A

Summary

G Medical Innovations beats Minerva Surgical on 4 of the 5 factors compared between the two stocks.

Get G Medical Innovations News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GMVDF vs. The Competition

Export

Metric	G Medical Innovations	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$26K	$46.05M	$7.16B	$12.48B
Dividend Yield	N/A	1.08%	2.66%	6.52%
P/E Ratio	N/A	20.75	28.02	24.70
Price / Sales	N/A	31.08	540.37	99.49
Price / Cash	N/A	18.86	49.26	57.09
Price / Book	N/A	8.46	10.96	6.46
Net Income	-$24.63M	-$20.01M	$3.57B	$337.01M

G Medical Innovations Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GMVDF G Medical Innovations	N/A	N/A	N/A	N/A	$26K	$4.42M	N/A	72
TTOO T2 Biosystems	N/A	$0.00 +233.3%	N/A	-98.6%	$42K	$7.68M	N/A	180	Gap Down
SDCCQ SmileDirectClub	N/A	N/A	N/A	N/A	$40K	$470.74M	N/A	2,700
VRAYQ ViewRay	N/A	N/A	N/A	N/A	$18K	$102.21M	N/A	300	News Coverage
AFIB Acutus Medical	N/A	N/A	N/A	N/A	$3K	$7.16M	N/A	340

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GMVDF) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

G Medical Innovations (GMVDF) Competitors

GMVDF vs. TTOO, SDCCQ, VRAYQ, AFIB, and UTRS

How does G Medical Innovations compare to T2 Biosystems?

Summary

How does G Medical Innovations compare to SmileDirectClub?

Summary

How does G Medical Innovations compare to ViewRay?

Summary

How does G Medical Innovations compare to Acutus Medical?

Summary

How does G Medical Innovations compare to Minerva Surgical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMVDF vs. The Competition

G Medical Innovations Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

G Medical Innovations (GMVDF) Competitors

GMVDF vs. TTOO, SDCCQ, VRAYQ, AFIB, and UTRS

How does G Medical Innovations compare to T2 Biosystems?

Is GMVDF or TTOO more profitable?

Do insiders & institutionals have more ownership in GMVDF or TTOO?

Which has more volatility & risk, GMVDF or TTOO?

Does the media refer more to GMVDF or TTOO?

Which has better valuation & earnings, GMVDF or TTOO?

Summary

How does G Medical Innovations compare to SmileDirectClub?

Which has more risk & volatility, GMVDF or SDCCQ?

Does the media prefer GMVDF or SDCCQ?

Do institutionals & insiders hold more shares of GMVDF or SDCCQ?

Is GMVDF or SDCCQ more profitable?

Which has stronger valuation & earnings, GMVDF or SDCCQ?

Summary

How does G Medical Innovations compare to ViewRay?

Which has stronger valuation and earnings, GMVDF or VRAYQ?

Which has more risk and volatility, GMVDF or VRAYQ?

Is GMVDF or VRAYQ more profitable?

Do insiders & institutionals hold more shares of GMVDF or VRAYQ?

Does the media prefer GMVDF or VRAYQ?

Summary

How does G Medical Innovations compare to Acutus Medical?

Which has better earnings and valuation, AFIB or GMVDF?

Which has more risk & volatility, AFIB or GMVDF?

Is AFIB or GMVDF more profitable?

Do insiders and institutionals hold more shares of AFIB or GMVDF?

Does the media prefer AFIB or GMVDF?

Summary

How does G Medical Innovations compare to Minerva Surgical?

Do institutionals & insiders hold more shares of UTRS or GMVDF?

Does the media prefer UTRS or GMVDF?

Which has better earnings & valuation, UTRS or GMVDF?

Which has more volatility and risk, UTRS or GMVDF?

Is UTRS or GMVDF more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMVDF vs. The Competition

G Medical Innovations Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools